Acadian Asset Management LLC Seagen Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$142.57 - $190.86 $309,519 - $414,357	-2,171 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $113,817 - $135,686	-799 Reduced 26.9%	2,171 $367,000
Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $630,688 - $752,175	-4,669 Reduced 61.12%	2,970 $469,000
Q1 2021 May 11, 2021	SELL	$137.51 - $190.8 $1.36 Million - $1.89 Million	-9,921 Reduced 56.5%	7,639 $1.06 Million
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $2.89 Million - $3.72 Million	17,560 New	17,560 $3.08 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.